Evidence map›Paper›PMID 27980598›Full record

ReviewNutrition & metabolism2016

Phytochemicals as novel agents for the induction of browning in white adipose tissue.

Yusra Azhar, Ashish Parmar, Colette N Miller, Janaiya S Samuels, Srujana Rayalam

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrition & metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03795792 (Efficacy of Oral Curcumin Administration on Metabolic Syndrome Remission.), which is not on this map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03795792 nacompletednot on this mapstarted 2018, after this paper: background citation

Efficacy of Oral Curcumin Administration on Metabolic Syndrome Remission.

TypeinterventionalSponsorCoordinación de Investigación en Salud, MexicoRan2018 to 2019Enrolled105ConditionsMetabolic SyndromeArmsCurcumin, Hydrolyzed collagen
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 99 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. International journal of molecular sciences · 2023
    Article
  9. International journal of molecular sciences · 2023
    Article
  10. Effect ofIndian journal of clinical biochemistry : IJCB · 2023
    Article
  11. Article
  12. Quercetin-3-Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia · 2023
    Article
  13. Foods (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yusra Azhar *Department of Pharmaceutical Sciences, School of Pharmacy, Philadelphia College of Osteopathic Medicine- GA Campus, 625 Old Peachtree Rd NW, Suwannee, GA 30024 USA.
Ashish Parmar *Department of Pharmaceutical Sciences, School of Pharmacy, Philadelphia College of Osteopathic Medicine- GA Campus, 625 Old Peachtree Rd NW, Suwannee, GA 30024 USA.
Colette N MillerDepartment of Foods and Nutrition, University of Georgia, Athens, GA USA.
Janaiya S SamuelsDepartment of Pharmaceutical Sciences, School of Pharmacy, Philadelphia College of Osteopathic Medicine- GA Campus, 625 Old Peachtree Rd NW, Suwannee, GA 30024 USA.
Srujana RayalamDepartment of Pharmaceutical Sciences, School of Pharmacy, Philadelphia College of Osteopathic Medicine- GA Campus, 625 Old Peachtree Rd NW, Suwannee, GA 30024 USA.ORCID 0000-0003-3550-6741
Philadelphia College of Osteopathic Medicine · USUniversity of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity and its associated metabolic syndrome continue to be a health epidemic in westernized societies and is catching up in the developing world. Despite such increases, little headway has been made to reverse adverse weight gain in the global population. Few medical options exist for the treatment of obesity which points to the necessity for exploration of anti-obesity therapies including pharmaceutical and nutraceutical compounds. Defects in brown adipose tissue, a major energy dissipating organ, has been identified in the obese and is hypothesized to contribute to the overall metabolic deficit observed in obesity. Not surprisingly, considerable attention has been placed on the discovery of methods to activate brown adipose tissue. A variety of plant-derived, natural compounds have shown promise to regulate brown adipose tissue activity and enhance the lipolytic and catabolic potential of white adipose tissue. Through activation of the sympathetic nervous system, thyroid hormone signaling, and transcriptional regulation of metabolism, natural compounds such as capsaicin and resveratrol may provide a relatively safe and effective option to upregulate energy expenditure. Through utilizing the energy dissipating potential of such nutraceutical compounds, the possibility exists to provide a therapeutic solution to correct the energy imbalance that underlines obesity.

Identifiers

PMID27980598
PMCPMC5135798
OpenAlexW2558745297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.